Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis

被引：0

作者：

Lee, J. ^{[1
]}

Park, Y. S. ^{[1
]}

Lee, C-H. ^{[1
]}

Lee, S-M. ^{[1
]}

Yoo, C-G. ^{[1
]}

Kim, Y. W. ^{[1
]}

Han, S. K. ^{[1
]}

Yim, J-J ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2013年 / 17卷 / 07期

关键词：

bronchial artery embolisation; aspirin; warfarin; ASPIRIN;

D O I：

10.5588/ijtld.12.0807

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The aim of this study was to assess whether the use of antiplatelets and anticoagulants increased haemoptysis in patients with bronchiectasis. Cases (n = 242) with a history of haemoptysis were compared with controls (n = 242) without a history of haemoptysis. Of the 242 case patients, 16.5% took antiplatelets compared with 19.8% of controls (P = 0.346). The proportion of warfarin users did not differ between cases and controls (3.3% vs. 2.5%, P = 0.588). The use of these agents might not be associated with increased risk of haemoptysis in patients with bronchiectasis.

引用

页码：989 / 991

页数：3

共 50 条

[1] Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy
Barequet, Irina S.
Sachs, Dan
Shenkman, Boris
Priel, Ayelet
Wasserzug, Yael
Budnik, Ivan
Moisseiev, Joseph
Salomon, Ophira
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2011, 37 (08) : 1434 - 1438
[2] Endoscopic sinus surgery in patients receiving anticoagulant or antiplatelet therapy
Sargi, Zoukaa
Casiano, Roy
AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (03): : 335 - 338
[3] Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients
Lip, Gregory Y. H.
Lane, Deirdre A.
REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (09): : 972 - 975
[4] Outcomes associated with combined antiplatelet and anticoagulant therapy
Johnson, Samuel G.
Rogers, Kristina
Delate, Thomas
Witt, Daniel M.
CHEST, 2008, 133 (04) : 948 - 954
[5] Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy
Tzoran, Inna
Brenner, Benjamin
Sakharov, Gleb
Trujillo-Santos, Javier
Lorenzo, Alicia
Madridano, Olga
Bosco Lopez-Saez, Juan
Monreal, Manuel
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (09) : 821 - 825
[6] Safety of percutaneous nephrolithotomy in patients on chronic anticoagulant or antiplatelet therapy
Fernandez-Baltar, C.
Perez-Fentes, D.
Sanchez-Garcia, J. F.
Garcia-Freire, C.
UROLITHIASIS, 2018, 46 (06) : 581 - 585
[7] Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery
Ryan, Andrea
Saad, Tahira
Kirwan, Caitriona
Keegan, David J.
Acheson, Robert W.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (04) : 387 - 395
[8] Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
Yan, Xiaodi
Wang, Baoyan
Xia, Peng
Lan, Chen
Wang, Qian
Ge, Weihong
Zhou, Yujie
Jiang, Chenxiao
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
[9] Indications for anticoagulant and antiplatelet combined therapy
Floyd, Christopher N.
Ferro, Albert
BMJ-BRITISH MEDICAL JOURNAL, 2017, 359
[10] Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience
Effron, Mark B.
Gibson, C. Michael
PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 531 - 536

← 1 2 3 4 5 →